Skip to main content
SpringerLink
Log in

18F-FDG PET/CT: Brain Imaging

  • Chapter
  • First Online:
PET/CT in Brain Disorders

Part of the book series: Clinicians’ Guides to Radionuclide Hybrid Imaging ((PET/CT))

  • 897 Accesses

Abstract

18F-2-Fluoro-2-deoxyglucose (18F-FDG) can be used to image regional cerebral glucose consumption which allows diagnostic imaging for a number of neurological indications such as dementia, epilepsy and movement disorders. Although not often used in neuro-oncology, it remains the method of choice in the diagnosis and staging of CNS lymphoma. Adhering to guidelines for patient preparation, using the correct imaging acquisition and reconstruction parameters, as well as defining the optimal image display for reporting are all crucial in order to obtain images of diagnostic quality. Furthermore, reporting images in the presence of neurological degenerative diseases can benefit hugely using additional post-processing and quantification of the images. This chapter summarises published guidelines, at the time of writing, on optimal imaging procedures for brain 18F-FDG PET/CT and introduces the reader to some of the more widely available quantification tools and references for optional further reading of developments in the field.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Purandare NC, Puranik A, Shah S. Common malignant brain tumors: can 18F-FDG PET/CT aid in differentiation? Nucl Med Commun. 2017;38(12):1109–16.

    PubMed  Google Scholar 

  2. Demetriades AK, Almeida AC, Bhangoo RS, Barrington SF. Applications of positron emission tomography in neuro-oncology: a clinical approach. Surgeon. 2014;12(3):148–57. https://doi.org/10.1016/j.surge.2013.12.001. Epub 2014 Mar 11

    PubMed  Google Scholar 

  3. Varrone A, Asenbaum S, Borght TV, Booij J, Nobili F, Nagren K, et al. EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2. Eur J Nucl Med Mol Imaging. 2009;36(12):2103–10.

    PubMed  Google Scholar 

  4. Waxman AD, Herholz K, Lewis DH, Herscovitch P, Minoshima S, Ichise M, et al. Society of nuclear medicine procedure guideline for FDG PET brain imaging. v1. Society of nuclear medicine molecular imaging. 2009.

    Google Scholar 

  5. Sarikaya I. PET studies in epilepsy. Am J Nucl Med Mol Imaging. 2015;5(5):416–30.

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Boellaard R, O’Doherty MJ, Weber WA, Mottaghy FM, Lonsdale MN, Stroobants SG, et al. FDG PET and PET/CT: EANM procedure guidlines for tumour PET imaging. v1. Eur J Nucl Med Mol Imaging. 2010;37(1):181–200.

    PubMed  Google Scholar 

  7. Leiderman DB, Albert P. The dynamics of metabolic change followingseizures as measured by positron emission tomography with fludeoxyglucose F 18. Arch Neurol. 1994;51(9):932–6.

    CAS  PubMed  Google Scholar 

  8. Administration of Radioactive Substances Advisory Committee. Notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactive sources. UK: Public Health England; March 2018.

    Google Scholar 

  9. Lassmann M, Biassoni L, Monsieurs M, Franzius C, EANM Dosimetry and Paediatrics Committees. The new EANM paediatric dosage card: additional notes with respect to F-18. Eur J Nucl Med Mol Imaging. 2008;35(9):1666–8.

    CAS  PubMed  Google Scholar 

  10. Tong S, Alessio AM, Kinahan PE. Image reconstruction for PET/CT scanners: past achievements and future challenges. Imaging Med. 2010;2(5):529–45.

    PubMed  PubMed Central  Google Scholar 

  11. Dickson JC, O’Meara C, Barnes A. A comparison of CT- and MR-based attenuation correction in neurological PET. Eur J Nucl Med Mol Imaging. 2014;41(6):1176–89.

    Google Scholar 

  12. Spetsieris PG, Ma Y, Dhawan V, Eidelberg D. Differential diagnosis of parkinsonian syndromes using PCA-based functional imaging features. NeuroImage. 2009;45(4):1241–52.

    PubMed  Google Scholar 

  13. Manda PK, Mahajan R, Dinovc ID. Structural brain atlases: design, rationale, and applications in normal and pathological cohorts. J Alzheimers Dis. 2012;31:169–88.

    Google Scholar 

  14. Brett M, Johnsrude IS, Owen AM. The problem of functional localization in the human brain. Nat Rev Neurosci. 2002;3:243–9.

    CAS  PubMed  Google Scholar 

  15. Mazziotta JC, Toga AW. A probabilistic atlas of the human brain: theory and rationale for its development: the international consortium for brain mapping (ICBM). NeuroImage. 1995;2:89–101.

    CAS  PubMed  Google Scholar 

  16. Minoshima S, Koeppe RA, Frey KA, Kuhl DE. Anatomic standardization: linear scaling and nonlinear warping of functional brain images. J Nucl Med. 1994;35(9):1528–37.

    CAS  PubMed  Google Scholar 

  17. Minoshima S, Kuhl DE, Foster NL, Koeppe RA, Frey KA. A diagnostic approach in alzheimer’s disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med. 1995;36(7):1238–48.

    Google Scholar 

  18. Borghammer P, Aanerud J, Gjedde A. Data-driven intensity normalization of PET group comparison studies is superior to global mean normalization. NeuroImage. 2009;46(4):981–8.

    PubMed  Google Scholar 

  19. Shen X, Liu H, Hu H, Shi P. The relationship between cerebral glucose metabolism and age: report of a large brain PET data set. PLoS One. 2012;7(12):e51517.

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Groeschel S, Vollmer B, King M, Connelly A. Developmental changes in cerebral grey and white matter volume from infancy to adulthood. Int J Dev Neurosci. 2010;28(6):481–9.

    CAS  PubMed  Google Scholar 

  21. Van Bogaert P, Wikler D, Damhaut P, Szliwowski H, Goldman S. Regional changes in glucose metabolism during brain development from the age of 6 years. NeuroImage. 1998;8(1):62–8.

    PubMed  Google Scholar 

  22. Kinnala A, Suhonen-Polvi H, Aärimaa T, Kero P, Korvenranta H, Ruotsalainen U, et al. Cerebral metabolic rate for glucose during the first six months of life: an FDG positron emission tomography study. Arch Dis Child Fetal Neonatal Ed. 1996;74(3):153–7.

    Google Scholar 

  23. De Blasi B, Barnes A, Galazzo IB, Hua C, Shulkin B, Koepp M, et al. Age-specific 18F-FDG image processing pipelines and analysis are essential for individual mapping of seizure foci in paediatric patients with intractable epilepsy. J Nucl Med. 2018; https://doi.org/10.2967/jnumed.117.203950.

    PubMed  PubMed Central  Google Scholar 

  24. Schenk V. Scenium v.1 and PET, white paper paper. USA: Siemens, Medical Solutions; 2006.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Nuclear Medicine, University College London Hospital NHS Foundation Trust, London, UK

    April-Louise Smith & Anna Barnes

Authors
  1. April-Louise Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anna Barnes
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to April-Louise Smith .

Editor information

Editors and Affiliations

  1. Institute of Nuclear Medicine, University College London, London, UK

    Francesco Fraioli

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Smith, AL., Barnes, A. (2019). 18F-FDG PET/CT: Brain Imaging. In: Fraioli, F. (eds) PET/CT in Brain Disorders. Clinicians’ Guides to Radionuclide Hybrid Imaging(). Springer, Cham. https://doi.org/10.1007/978-3-030-01523-7_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-01523-7_4

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-01522-0

  • Online ISBN: 978-3-030-01523-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation